NCT05046262

Brief Summary

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 8, 2020

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 8, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 16, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 22, 2022

Completed
Last Updated

September 16, 2021

Status Verified

September 1, 2021

Enrollment Period

2.1 years

First QC Date

September 8, 2021

Last Update Submit

September 8, 2021

Conditions

Basal Cell Carcinoma

Outcome Measures

Primary Outcomes (1)

  • complete response

    3 months

Interventions

Calcium chlorideDRUG

Calcium electroporation

Also known as: electroporation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Primary low risk basal cell carcinoma less than 3 cm in diameter

You may not qualify if:

  • Immunosuppression or organ transplant recipients Pregnancy or breastfeeding Allergy to local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Dermatology, Bispebjerg Hospital

Copenhagen, 2400, Denmark

RECRUITING

MeSH Terms

Conditions

Carcinoma, Basal Cell

Interventions

Calcium ChlorideElectroporation

Condition Hierarchy (Ancestors)

CarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsNeoplasms, Basal Cell

Intervention Hierarchy (Ancestors)

Calcium CompoundsInorganic ChemicalsChloridesHydrochloric AcidChlorine CompoundsCytological TechniquesClinical Laboratory TechniquesInvestigative TechniquesElectrochemical Techniques

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, DMSc

Study Record Dates

First Submitted

September 8, 2021

First Posted

September 16, 2021

Study Start

January 8, 2020

Primary Completion

February 22, 2022

Study Completion

February 22, 2022

Last Updated

September 16, 2021

Record last verified: 2021-09

Locations

DK(1)